Cardinal Health Inc. (CAH) Financial Statements (2024 and earlier)

Company Profile

Business Address 7000 CARDINAL PLACE
DUBLIN, OH 43017
State of Incorp. OH
Fiscal Year End June 30
Industry (SIC) 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

3/31/2024
MRQ
12/31/2023
MRQ
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,5914,0434,7173,4072,7712,531
Cash and cash equivalents4,5914,0434,7173,4072,7712,531
Receivables11,78811,34410,5619,1038,2648,448
Inventory, net of allowances, customer advances and progress billings18,45115,94015,63614,59413,19812,822
Inventory18,45115,94015,63614,59413,19812,822
Other current assets2,8162,3622,0212,8431,7071,946
Other undisclosed current assets12144 1,101  
Total current assets:37,65833,83332,93531,04825,94025,747
Noncurrent Assets
Property, plant and equipment2,4462,4622,3612,3602,3662,356
Intangible assets, net (including goodwill)5,3716,0817,62910,09411,27511,808
Goodwill4,0244,6095,8557,9898,3578,378
Intangible assets, net (excluding goodwill)1,3471,4721,7742,1052,9183,430
Other noncurrent assets1,0981,0419539511,1851,052
Total noncurrent assets:8,9159,58410,94313,40514,82615,216
TOTAL ASSETS:46,57343,41743,87844,45340,76640,963
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities37,09832,87229,97026,65723,60523,657
Accounts payable34,25929,81327,12823,70021,37421,535
Accrued liabilities2,8393,0592,8422,9572,2312,122
Debt1,18879258087110452
Other undisclosed current liabilities  42 96  
Total current liabilities:38,28633,70630,55027,62423,61524,109
Noncurrent Liabilities
Long-term debt and lease obligation, including:3,5353,9094,7355,3656,7657,579
Finance lease, liability  59494525
Other undisclosed long-term debt and lease obligation3,5353,8504,2985,3206,3997,579
Liabilities, other than long-term debt  375   1,749
Deferred tax liabilities, net1,749
Operating lease, liability  375388 341
Other undisclosed noncurrent liabilities8,1998,2788,9119,6708,2531,196
Total noncurrent liabilities:11,73412,56214,03415,03515,35910,524
Total liabilities:50,02046,26844,58442,65938,97434,633
Equity
Equity, attributable to parent(3,449)(2,852)(709)1,7911,7896,328
Common stock2,8552,7472,8132,8062,7892,763
Treasury stock, value(5,724)(4,914)(3,128)(2,186)(2,066)(1,790)
Accumulated other comprehensive loss(155)(151)(114)(34)(104)(79)
Retained earnings (accumulated deficit)(425)(534)(280)1,2051,1705,434
Equity, attributable to noncontrolling interest213332
Total equity:(3,447)(2,851)(706)1,7941,7926,330
TOTAL LIABILITIES AND EQUITY:46,57343,41743,87844,45340,76640,963

Income Statement (P&L) ($ in millions)

3/31/2024
TTM
12/31/2023
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
Revenues216,148205,012181,364162,467152,922145,534
Cost of revenue
(Cost of Goods and Services Sold)
(208,922)(198,123)(174,819)(155,689)(146,054)(138,700)
Gross profit:7,2266,8896,5456,7786,8686,834
Operating expenses(4,854)(4,627)(4,767)(5,776)(10,435)(4,641)
Other undisclosed operating loss(1,195)(1,535)(2,374)(530)(531)(133)
Operating income (loss):1,177727(596)472(4,098)2,060
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
174(16)471(15)
Interest and debt expense(65)(93)(159)(194)(254)(294)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes    (2)579 
Income (loss) from continuing operations before equity method investments, income taxes:1,129638(771)323(3,772)1,751
Income from equity method investments     2 
Other undisclosed income (loss) from continuing operations before income taxes  2   
Income (loss) from continuing operations before income taxes:1,129638(769)323(3,770)1,751
Income tax expense (benefit)(488)(376)(163)28979(386)
Income (loss) from continuing operations:641262(932)612(3,691)1,365
Income (loss) before gain (loss) on sale of properties:(932)612(3,691)1,365
Other undisclosed net loss     (2) 
Net income (loss):641262(932)612(3,693)1,365
Net loss attributable to noncontrolling interest(2)(1)(1)(1)(3)(2)
Net income (loss) available to common stockholders, diluted:639261(933)611(3,696)1,363

Comprehensive Income ($ in millions)

3/31/2024
TTM
12/31/2023
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
Net income (loss):641262(932)612(3,693)1,365
Other comprehensive income (loss)(9)(37)(80)70(25)13
Comprehensive income (loss):632225(1,012)682(3,718)1,378
Comprehensive loss, net of tax, attributable to noncontrolling interest(2)(1)(1)(1)(3)(2)
Comprehensive income (loss), net of tax, attributable to parent:630224(1,013)681(3,721)1,376

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: